Clinical Features and Genetic Insights in Pediatric Patients with Sodium Taurocholate Cotransporting Polypeptide Deficiency
Overview
This study investigates the clinical features and genetic spectrum of sodium taurocholate cotransporting polypeptide deficiency (NTCPD) in a pediatric cohort. It identifies significant clinical heterogeneity among patients and highlights the predominance of specific genetic variants.
Background
NTCPD is an autosomal recessive disorder caused by mutations in the SLC10A1 gene, leading to impaired bile acid transport. Understanding the clinical manifestations and genetic underpinnings of NTCPD is crucial for effective diagnosis and management in pediatric patients. This study aims to enhance clinical awareness and guide future research on genotype-phenotype correlations.
Data Highlights
Group
Number of Patients
Age (years)
γ-GT Levels
Jaundice
9
Significantly younger (p = 0.003)
Markedly elevated (p = 0.001)
Incidental Hypercholanemia
10
Older
Normal
Key Findings
19 children diagnosed with NTCPD were analyzed, revealing heterogeneous clinical presentations.
Patients were categorized into jaundice (n = 9) and incidental hypercholanemia (n = 10) groups.
The homozygous c.800C > T (p.Ser267Phe) variant was the most prevalent, found in 14 out of 19 patients.
Four novel genetic variants were identified: c.101T > C, c.551delT, c.896T > C, and c.654_674dup.
All patients normalized liver function parameters during a 12-month follow-up.
Elevated γ-GT levels suggest potential biliary system involvement in the disease's pathophysiology.
Clinical Implications
Clinicians should consider NTCPD in pediatric patients presenting with jaundice or hypercholanemia, particularly in the context of elevated γ-GT levels. Genetic testing for SLC10A1 mutations can aid in diagnosis and management, and ongoing monitoring is essential for assessing long-term outcomes.
Conclusion
This study enhances the understanding of NTCPD in children, emphasizing the need for awareness of its clinical variability and genetic basis. Future research should focus on multi-center collaborations to further elucidate the disease's natural history and management strategies.
